Research
Mixed
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with metabolic syndrome, with prevalence rates of obesity (51%), type 2 diabetes (23%), and dyslipidemia (69%) significantly higher in NAFLD patients compared to the general population.
If you have fatty liver, check your metabolic health. High rates of obesity, diabetes, and high cholesterol are common companions. Managing these metabolic factors is crucial for liver health.
GoodSupportsHIGH confidence
NAFLD is strongly associated with metabolic comorbidities such as obesity (51%), type 2 diabetes (22.5%), dyslipidemia (69%), and hypertension (39.3%) [37].
Why this rating
Based on a large meta-analysis (Younossi et al.) cited in the review.
Source
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello et al. · International Journal of Molecular Sciences · 2019
DOI 10.3390/ijms20081948
narrative_reviewCited 190×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Insulin resistance is a key pathophysiological factor in NAFLD, creating a bidirectional relationship where insulin resistance leads to liver fat accumulation and liver fat accumulation worsens insulin sensitivity.Strong
- Genetic variants, particularly PNPLA3 (rs738409 C>G), are strongly associated with liver steatosis and progression of liver damage, independent of insulin sensitivity and BMI.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →